Form 8-K

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): July 26, 2012

 

Amarin Corporation plc

(Exact name of registrant as specified in its charter)

 

 

England and Wales

 

0-21392

 

Not applicable

(State or other jurisdiction of
incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

 

2 Pembroke House, Upper Pembroke

Street 28-32,

Dublin 2, Ireland

 

Not applicable

(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: +353 1 6699 020

Not Applicable

Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 


Item 8.01. Other Events

On July 26, 2012, Amarin Corporation plc issued a press release titled, “Amarin Announces FDA Approval of VascepaTM (icosapent ethyl) Capsules for the Reduction of Triglyceride Levels in Adult Patients with Severe (TG>500mg/dL) Hypertriglyceridemia.”

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits

(d) Exhibits.

 

Exhibit No.

  

Description

99.1    Press Release dated July 26, 2012.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

AMARIN CORPORATION PLC
By:   /s/ John Thero
 

John Thero

President

Date: July 27, 2012


EXHIBIT INDEX

 

 

Exhibit No.

  

Description

99.1    Press Release dated July 26, 2012.